Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Non-alcoholic Fatty Liver Disease
|
222 | 0.557 | 0.720 | 22 | 43928847 | missense variant | C/G | snv | 0.28 | 0.22 | 0.900 | 0.953 | 149 | 2009 | 2020 | ||||
Steatohepatitis
|
75 | 0.557 | 0.720 | 22 | 43928847 | missense variant | C/G | snv | 0.28 | 0.22 | 0.100 | 0.944 | 89 | 2009 | 2020 | ||||
Liver diseases
|
100 | 0.557 | 0.720 | 22 | 43928847 | missense variant | C/G | snv | 0.28 | 0.22 | 0.100 | 1.000 | 28 | 2011 | 2020 | ||||
Renal tubular injury
|
1 | 0.557 | 0.720 | 22 | 43928847 | missense variant | C/G | snv | 0.28 | 0.22 | 0.010 | 1.000 | 1 | 2020 | 2020 | ||||
Respiratory Tract Infections
|
10 | 0.557 | 0.720 | 22 | 43928847 | missense variant | C/G | snv | 0.28 | 0.22 | 0.010 | 1.000 | 1 | 2020 | 2020 | ||||
Fatty Liver
|
35 | 0.557 | 0.720 | 22 | 43928847 | missense variant | C/G | snv | 0.28 | 0.22 | 0.100 | 1.000 | 45 | 2009 | 2019 | ||||
Liver carcinoma
|
942 | 0.557 | 0.720 | 22 | 43928847 | missense variant | C/G | snv | 0.28 | 0.22 | 0.100 | 0.946 | 37 | 2011 | 2019 | ||||
Fatty Liver Disease
|
81 | 0.557 | 0.720 | 22 | 43928847 | missense variant | C/G | snv | 0.28 | 0.22 | 0.800 | 1.000 | 29 | 2010 | 2019 | ||||
Liver Cirrhosis
|
189 | 0.557 | 0.720 | 22 | 43928847 | missense variant | C/G | snv | 0.28 | 0.22 | 0.100 | 0.862 | 29 | 2011 | 2019 | ||||
Cirrhosis
|
110 | 0.557 | 0.720 | 22 | 43928847 | missense variant | C/G | snv | 0.28 | 0.22 | 0.100 | 0.889 | 27 | 2011 | 2019 | ||||
Fibrosis, Liver
|
64 | 0.557 | 0.720 | 22 | 43928847 | missense variant | C/G | snv | 0.28 | 0.22 | 0.100 | 0.958 | 24 | 2010 | 2019 | ||||
Hepatitis C
|
347 | 0.557 | 0.720 | 22 | 43928847 | missense variant | C/G | snv | 0.28 | 0.22 | 0.100 | 0.905 | 21 | 2011 | 2019 | ||||
Hepatitis C, Chronic
|
80 | 0.557 | 0.720 | 22 | 43928847 | missense variant | C/G | snv | 0.28 | 0.22 | 0.100 | 0.938 | 16 | 2011 | 2019 | ||||
Obesity
|
1111 | 0.557 | 0.720 | 22 | 43928847 | missense variant | C/G | snv | 0.28 | 0.22 | 0.100 | 1.000 | 16 | 2008 | 2019 | ||||
Alcoholic Liver Diseases
|
20 | 0.557 | 0.720 | 22 | 43928847 | missense variant | C/G | snv | 0.28 | 0.22 | 0.100 | 1.000 | 14 | 2011 | 2019 | ||||
Nonalcoholic Steatohepatitis
|
17 | 0.557 | 0.720 | 22 | 43928847 | missense variant | C/G | snv | 0.28 | 0.22 | 0.100 | 1.000 | 13 | 2010 | 2019 | ||||
Metabolic Syndrome X
|
591 | 0.557 | 0.720 | 22 | 43928847 | missense variant | C/G | snv | 0.28 | 0.22 | 0.100 | 1.000 | 11 | 2012 | 2019 | ||||
Pseudohyperkalemia Cardiff
|
60 | 0.557 | 0.720 | 22 | 43928847 | missense variant | C/G | snv | 0.28 | 0.22 | 0.100 | 1.000 | 11 | 2011 | 2019 | ||||
Diabetes Mellitus, Non-Insulin-Dependent
|
2672 | 0.557 | 0.720 | 22 | 43928847 | missense variant | C/G | snv | 0.28 | 0.22 | 0.790 | 1.000 | 10 | 2010 | 2019 | ||||
Hepatitis B
|
519 | 0.557 | 0.720 | 22 | 43928847 | missense variant | C/G | snv | 0.28 | 0.22 | 0.730 | 1.000 | 4 | 2011 | 2019 | ||||
Cardiovascular Diseases
|
711 | 0.557 | 0.720 | 22 | 43928847 | missense variant | C/G | snv | 0.28 | 0.22 | 0.030 | 1.000 | 3 | 2017 | 2019 | ||||
Cholecystolithiasis
|
62 | 0.557 | 0.720 | 22 | 43928847 | missense variant | C/G | snv | 0.28 | 0.22 | 0.030 | 1.000 | 3 | 2011 | 2019 | ||||
Cholelithiasis
|
90 | 0.557 | 0.720 | 22 | 43928847 | missense variant | C/G | snv | 0.28 | 0.22 | 0.030 | 1.000 | 3 | 2011 | 2019 | ||||
alcohol-related liver disease
|
2 | 0.557 | 0.720 | 22 | 43928847 | missense variant | C/G | snv | 0.28 | 0.22 | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||
Chronic Kidney Diseases
|
306 | 0.557 | 0.720 | 22 | 43928847 | missense variant | C/G | snv | 0.28 | 0.22 | 0.010 | 1.000 | 1 | 2019 | 2019 |